Nástroje

iconicon Akciový screener
iconicon Kalendář zisků
iconicon Super investoři

Ostatní

iconicon Návod
IČ: 19940963

5. května 521, 501 01 Turnov
Zásady GDPR
Podmínky služby
Všechna práva vyhrazena @ 2024, Fundamenty.cz
Proudly created by draftspot.net
Xeris Biopharma Holdings, Inc.
Xeris Biopharma Holdings, Inc.
XERS
Valuace
100
Růst
86
Zdraví
63
Cena
$ 7.49
Dnes
+0.11 (1.48%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
1.2B
Obrat
0B
Zisk
0B
Aktiva
0B
Dluh
0B
ROE
1816%
ROA
-4%
PE
1768
PS
3
Cena 1R
3-10
⌀ Cena
6.45
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
05-03-2026
Poslední dividenda

Profil

Společnost Xeris Biopharma Holdings, Inc., biofarmaceutická společnost, se zabývá vývojem a komercializací terapií pro populace pacientů v endokrinologii, neurologii a gastroenterologii. Společnost uvádí na trh Gvoke, tekutý glukagon připravený k použití pro léčbu těžké hypoglykémie, a Keveyis, terapii pro léčbu hyperkalémie, hypokalémie a příbuzných variant primární periodické paralýzy; a Recorlev, inhibitor kortizolové syntézy, prokázal pro léčbu endogenní hyperkortizolemie u dospělých pacientů s Cushingovým syndromem. Má také řadu vývojových programů, které rozšiřují výrobky uváděné na trh na nové indikace a použití a přinášejí nové výrobky s využitím svých proprietárních technologických platforem formulace, XeriSol a XeriJect. Společnost byla založena v roce 2005 a sídlí v Chicagu ve státě Illinois.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
394
Založení
2018-06-21
Adresa
180 North LaSalle Street
CEO
John P. Shannon
Web
www.xerispharma.com

Podobné společnosti

IMCR
Immunocore Holdings plc
$ 34.98
+ $ 1.48
ABCL
AbCellera Biologics Inc.
$ 3.89
- $ 0.03
BHVN
Biohaven Ltd.
$ 8.11
- $ 0.16
VERA
Vera Therapeutics, Inc.
$ 28.27
+ $ 4.08
CLDX
Celldex Therapeutics, Inc.
$ 22.78
- $ 0.12
JANX
Janux Therapeutics, Inc.
$ 27.09
+ $ 0.61
BCRX
BioCryst Pharmaceuticals, Inc.
$ 7.19
+ $ 0.10

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 202520242023202220212020201920182017
Total Revenues291.8291.8203.1110.2110.249.620.22.51.61.1
Cost of Revenues53.453.436.822.622.613.39.30.00.00.0
Gross Profit238.4238.4166.287.687.636.310.82.41.61.1
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues85.874.471.560.160.154.348.140.638.033.2
Cost of Revenues19.111.014.68.79.513.610.56.07.65.3
Gross Profit66.763.456.951.450.640.737.634.730.527.9
Operating Income TTM 202520242023202220212020201920182017
R&D Expenses0.00.00.021.021.025.220.940.720.210.2
Selling General & Admin Expenses0.00.00.0137.7137.7125.773.721.18.04.1
Depreciation & Amortization12.512.212.612.710.80.63.00.30.20.1
Total Operating Expenses213.5213.5199.9169.6169.6151.494.461.828.214.3
Operating Income24.924.9-33.6-81.9-81.9-115.2-83.5-59.3-26.6-13.2
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.00.00.00.00.00.00.00.06.14.8
Selling General & Admin Expenses0.00.00.00.00.00.00.00.037.633.6
Depreciation & Amortization3.03.23.23.13.13.13.23.23.43.2
Total Operating Expenses50.056.752.454.548.953.645.848.946.441.2
Operating Income16.86.74.5-3.11.7-12.9-8.2-14.2-16.0-13.3
Net Income TTM 202520242023202220212020201920182017
Interest Income4.74.75.32.62.60.33.01.60.10.0
Interest Expense29.129.133.215.315.37.210.72.50.00.0
Other Expense-24.3-24.3-23.5-14.1-14.1-7.6-7.70.20.00.0
IBT0.60.6-57.1-96.1-96.1-122.7-91.3-60.1-26.6-13.2
Income Tax Expense0.00.0-2.3-1.4-1.4-0.1-0.11.80.00.0
Net Income0.60.6-54.8-94.7-94.7-122.7-91.1-60.1-26.6-13.2
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income1.51.20.91.20.91.21.31.91.21.3
Interest Expense7.27.37.47.37.77.88.07.06.56.2
Other Expense-5.7-6.1-6.4-6.1-6.8-6.2-6.1-4.4-4.5-3.6
IBT11.10.6-1.9-9.2-5.1-19.1-14.3-18.7-20.5-16.8
Income Tax Expense0.00.00.00.00.0-3.30.70.3-0.72.8
Net Income11.10.6-1.9-9.2-5.1-15.7-15.0-19.0-19.8-16.8
Per Share Data TTM 202520242023202220212020201920182017
EPS$0.00$0.00$0.00$-0.70$-0.70$-1.55$-2.14$-4.99$-12.24$-6.09
EPS Diluted$0.00$0.00$0.00$-0.70$-0.70$-1.55$-2.14$-4.99$-12.24$-6.09
Shares Outstanding166.0160.4146.8135.6135.679.042.612.02.22.2
Diluted Shares Outstanding180.1172.7146.8135.6135.679.042.612.02.22.2
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.14$-0.12
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.14$-0.12
Shares Outstanding166.0177.6156.0152.4149.1149.0148.3140.5137.3137.1
Diluted Shares Outstanding180.1177.6156.0152.4149.1149.0148.3140.5137.3137.1
Current Assets TTM 20242023202220212020201920182017
Cash And Equivalents57.671.6122.0122.067.337.645.742.032.3
Short Term Investments20.00.00.035.235.296.266.90.00.0
Total Cash & ST Investments77.671.6122.0122.0102.4133.8112.642.032.3
Accounts Receivable42.440.430.830.817.56.92.91.20.1
Inventory43.048.224.724.718.18.40.00.00.0
Other Current Assets7.47.59.39.34.63.22.40.80.8
Total Current Assets170.3167.7186.8186.8142.6152.2117.944.133.2
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents91.659.358.471.659.257.662.746.251.046.2
Short Term Investments0.00.00.00.010.220.024.734.544.134.5
Total Cash & ST Investments91.659.358.471.669.477.687.480.795.180.7
Accounts Receivable53.853.046.340.441.142.437.430.230.930.8
Inventory67.567.352.748.245.143.040.936.529.036.5
Other Current Assets11.26.06.07.57.17.47.68.310.59.3
Total Current Assets224.0185.6163.5167.7162.8170.3173.3155.7165.5155.7
Long-Term Assets TTM 20242023202220212020201920182017
Net Property, Plant & Equipment28.728.228.428.46.66.72.00.80.3
Goodwill22.922.9120.6120.622.90.00.00.00.0
Intangible Assets104.398.94.04.0131.50.00.00.00.0
Long-Term Investments4.24.14.30.00.013.20.00.00.0
Other Long-Term Assets1.3-4.80.34.70.8-13.00.10.20.0
Total Long-Term Assets161.4155.4157.7157.7161.86.92.10.90.4
Total Assets331.7323.1344.5344.5304.4159.2120.045.033.5
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment27.227.727.828.228.428.728.830.210.430.2
Goodwill22.922.922.922.922.922.922.922.922.922.9
Intangible Assets90.893.596.298.9101.6104.3107.1115.2117.9115.2
Long-Term Investments0.00.04.14.10.04.20.00.04.34.3
Other Long-Term Assets5.35.11.01.35.41.34.64.84.70.3
Total Long-Term Assets146.2149.1152.0155.4158.3161.4163.3173.0155.8173.0
Total Assets370.2334.7315.5323.1321.1331.7336.6328.8321.4328.8
Current Liabilities TTM 20242023202220212020201920182017
Accounts Payable5.82.34.64.68.93.10.92.01.3
Short-Term Debt5.321.23.21.60.00.08.22.60.9
Other Current Liabilities64.477.065.967.470.125.10.90.10.0
Current Liabilities75.5100.473.673.679.028.210.24.92.5
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable6.59.56.42.37.55.87.111.612.04.6
Short-Term Debt6.26.218.121.221.15.34.63.92.91.6
Other Current Liabilities103.579.670.677.062.564.461.464.266.567.4
Current Liabilities116.295.295.1100.491.075.573.179.781.479.7
Long-Term Liabilities TTM 20242023202220212020201920182017
Long-Term Debt230.5250.3196.5196.588.187.031.90.00.0
Capital Leases34.039.311.011.00.00.00.00.00.0
Def. Tax Liability3.30.03.53.54.90.00.00.00.0
Total Liabilities351.0352.7299.3299.3209.1125.444.6102.865.5
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt32.0251.1250.7250.3249.9264.5264.1223.1197.0196.5
Capital Leases38.238.639.039.339.734.039.036.810.836.8
Def. Tax Liability0.00.00.00.00.03.32.62.83.52.8
Total Liabilities371.1354.0350.6352.7349.4351.0345.8315.1291.3315.1
Total Common Equity TTM 20242023202220212020201920182017
Common Stock0.00.00.00.00.00.00.00.00.0
Retained Earnings-651.0-671.9-554.8-554.8-460.1-337.4-120.7-60.6-34.0
Comprehensive Income0.00.00.00.00.00.0-0.1-0.4-0.3
Total Common Equity-19.3-29.645.245.295.233.875.4-57.8-31.9
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock0.00.00.00.00.00.00.00.00.00.0
Retained Earnings-682.4-683.0-681.1-671.9-666.7-651.0-636.0-591.4-571.6-591.4
Comprehensive Income0.00.00.00.00.00.00.0-0.10.0-0.1
Total Common Equity-0.9-19.3-35.1-29.6-28.3-19.3-9.213.630.013.6
Other TTM 20242023202220212020201920182017
Total Debt269.8271.4198.1198.188.187.031.90.00.0
Book Value-19.3-29.645.245.295.233.875.4-57.8-31.9
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.00.00.00.00.00.00.00.00.00.0
Book Value-0.9-19.3-35.1-29.6-28.3-19.3-9.213.630.013.6
Cash Flow From Operating Activities TTM 202520242023202220212020201920182017
Net Income-59.60.6-54.8-94.7-94.7-122.7-91.1-60.1-26.6-13.2
Depreciation & Amortization13.012.212.612.712.71.91.50.30.20.1
Stock-Based Compensation13.222.418.412.212.211.48.31.70.50.5
Change Working Capital-1.9-10.4-8.8-35.2-35.211.9-2.81.61.1-3.6
Change In Accounts Receivable-12.2-10.6-1.2-13.4-13.4-6.2-2.2-1.7-1.10.2
Change In Accounts Payable-6.1-0.1-9.6-4.3-4.35.5-2.5-1.10.7-2.9
Change In Inventories-8.2-19.3-8.8-7.5-7.5-7.4-5.14.01.7-0.8
Other Non-cash Items28.33.9-2.03.53.51.03.10.60.10.0
Cash from Operations-39.00.00.0-102.9-102.9-95.5-80.6-56.3-24.7-16.1
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income11.10.6-1.9-9.2-5.1-15.7-15.0-19.0-19.8-16.8
Depreciation & Amortization3.03.02.93.13.12.73.23.23.43.2
Stock-Based Compensation5.37.65.04.43.66.84.23.82.92.6
Change Working Capital-0.46.1-6.9-9.2-0.59.0-3.4-5.60.4-13.9
Change In Accounts Receivable2.7-0.7-6.7-5.90.71.3-5.01.80.60.0
Change In Accounts Payable-1.72.0-4.44.1-5.21.7-1.6-4.50.16.9
Change In Inventories-4.0-4.1-7.6-3.6-3.1-1.0-2.3-2.3-7.4-3.8
Other Non-cash Items1.01.01.10.80.8-7.7-0.1-3.0-0.2-0.8
Cash from Operations0.00.00.00.00.00.00.00.0-13.7-26.1
Cash Flow From Investing Activities TTM 202520242023202220212020201920182017
Capital Expenditure-1.0-0.7-0.9-0.5-0.5-1.1-0.4-1.5-0.70.0
Acquisitions0.00.00.00.038.538.50.40.00.00.0
Investments-29.50.0-34.50.0-43.0-43.0-101.8-68.90.00.0
Sales of Investment45.00.040.235.035.0103.674.72.10.00.0
Other Investing Activities10.50.00.035.04.60.0-0.40.00.00.0
Cash from Investing14.50.00.034.534.598.0-27.4-68.3-0.70.0
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure-0.3-0.40.00.0-0.2-0.1-0.4-0.2-1.5-0.2
Acquisitions0.00.00.00.00.00.00.00.00.00.0
Investments0.00.00.00.00.0-5.0-5.0-24.50.0-43.7
Sales of Investment0.00.00.00.010.215.010.05.010.00.0
Other Investing Activities0.00.00.00.00.00.00.00.010.0-43.7
Cash from Investing0.00.00.00.00.00.00.00.08.5-44.0
Cash Flow From Financing Activities TTM 202520242023202220212020201920182017
Debt Repaid-38.20.00.0102.7-43.5-25.1-25.10.00.00.0
Debt Issued83.0271.473.4300.8153.526.180.231.90.00.0
Issuance of Common Stock1.10.00.030.030.027.065.998.30.00.0
Repurchase of Common Stock-3.6-10.9-3.7-0.5-0.5-0.5-0.10.00.00.0
Dividends Paid0.00.00.00.00.0-25.1-95.60.00.00.0
Other Financing Activities-12.60.00.0-4.8141.451.0181.029.935.13.9
Cash from Financing35.70.00.0127.5127.527.2126.1128.235.13.9
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.00.00.00.00.00.00.00.00.00.0
Debt Issued38.2-219.0-11.5-2.70.51.21.143.726.6-26.6
Issuance of Common Stock0.00.00.00.00.00.00.00.00.00.0
Repurchase of Common Stock-1.5-0.58.0-8.0-0.2-0.1-0.1-3.40.0-0.9
Dividends Paid0.00.00.00.00.00.00.00.00.00.0
Other Financing Activities0.00.00.00.00.00.00.00.00.60.0
Cash from Financing0.00.00.00.00.00.00.00.00.6-0.9
Cash position TTM 202520242023202220212020201920182017
Net Change in Cash11.439.34.159.059.029.718.13.79.8-12.2
Closing Cash Balance57.6115.175.7126.3126.367.337.645.742.032.3
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash19.432.20.8-13.212.41.5-5.1-4.8-4.7-71.0
Closing Cash Balance115.195.659.362.675.763.457.662.750.655.3
Free Cash Flow TTM 202520242023202220212020201920182017
Free Cash Flow-40.027.9-37.8-103.4-103.4-96.6-80.9-57.8-25.4-16.1
Real Free Cash Flow-53.25.6-56.2-115.6-115.6-108.0-89.2-59.5-25.9-16.7
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow19.718.110.0-10.01.8-8.4-10.7-20.5-15.3-26.4
Real Free Cash Flow14.410.45.0-14.5-1.8-15.2-15.0-24.2-18.2-28.9
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E1768.211.1-1.4
P/S3.432.49.4
P/B-1137.7-80.25.2
P/FCF63.6-69.3-1.5
Market cap$1.2$1.6
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets10.3 %45.3 %0 %
Debt to Income6892.6 %-158 %0 %
Debt to Free cash flow247.7 %-92.2 %0 %
Interest expense percentage116.8 %-13.4 %44.7 %
Current ratio1.9 4.6 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE-64.3 %-16.4 %0 %
ROA0.1 %-42 %0 %
CapEx to Revenue0.2 %23 %0 %
RaD to Revenue0 %736.4 %0 %
ROEM740,723.4 81506.4

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin83.5 %78.1 %68.7 %
Operating margin3.7 %-1254.4 %35.5 %
Net margin-5.9 %-1284.1 %9.5 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %3.9 %0 %
Dividend payout percentage0 %-11.3 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding177.6 mil 76.5 mil
Employee count0.4 tis 0.4 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás
Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader